Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study

EBIOMEDICINE Volume 57 published_at 2020-07
アクセス数 : 1326
ダウンロード数 : 0

今月のアクセス数 : 69
今月のダウンロード数 : 0
Title
Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study
Creator
Fukuhara Tatsuro
Saito Haruhiro
Furuya Naoki
Watanabe Kana
Sugawara Shunichi
Iwasawa Shunichiro
Tsunezuka Yoshio
Yamaguchi Ou
Okada Morihito
Yoshimori Kozo
Nakachi Ichiro
Gemma Akihiko
Azuma Koichi
Kurimoto Futoshi
Fujita Yuka
Nagashima Hiromi
Asai Gyo
Watanabe Satoshi
Miyazaki Masaki
Hagiwara Koichi
Nukiwa Toshihiro
Morita Satoshi
Kobayashi Kunihiko
Maemondo Makoto
Source Title
EBIOMEDICINE
Volume 57
Journal Identifire
ISSN 2352-3964
Language
eng
Resource Type journal article
Publisher
ELSEVIER
Date of Issued 2020-07
Access Rights metadata only access
Relation
[DOI] 10.1016/j.ebiom.2020.102861
[PMID] 32629391